Roche Holding AG (ROG.SW) SIX
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
Roche Holding AG
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
103249
First IPO Date
August 03, 1995
Key Executives
| Name | Title | Pay | Year Born |
| Thomas Schinecker | Group Chief Executive Officer | 3.87M | 1975 |
| Maria Cristina A. Wilbur | Chief People Officer | 2.92M | 1967 |
| Alan Hippe | Chief Financial Officer | 4.11M | 1967 |
| Severin Schwan | Executive Chairman | 7.51M | 1967 |
| Barbara Schadler | Head of Group Communications | 0 | 1962 |
| Claudia Bockstiegel | General Counsel | 0 | 1964 |
| Aviv Regev | Head of Genentech Research & Early Development (gRED) | 0 | 1971 |
| Levi Garraway | Executive VP, Head of Global Product Development & Chief Medical Officer | 0 | 1969 |
| Nina Schwab-Hautzinger | Head of Group Communications | 0 | 1975 |
| Chris Brittain | Global Head of Ophthalmology Product Development & Vice President | 0 | N/A |
| Boris L. Zaitra | Head of Corporate Business Development | 0 | 1972 |
| Bruno Eschli | Head of Investor Relations | 0 | N/A |
| John Young | Global Head of Infectious Diseases of Roche Pharma Research & Early Development | 0 | N/A |
| Ann Costello | Global Head of Roche Diagnostics Solutions | 0 | N/A |
| Jill German | President of Roche Tissue Diagnostics | 0 | N/A |
| Pascale Schmidt | Chief Compliance Officer | 0 | 1973 |
| Palani Kumaresan | Head of Research & Development - Roche Diagnostics | 0 | N/A |
| Nicolas Dunant | Head of Group Media Relations | 0 | N/A |
Description
Roche Holding AG is a global healthcare company specializing in pharmaceuticals and diagnostics, with significant operations in Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international regions. Its comprehensive portfolio of pharmaceutical products addresses conditions across oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolism, ophthalmology, and respiratory health. Additionally, the company develops treatments for specific ailments such as anemia, dermatological conditions, hemophilia, inflammatory and autoimmune disorders, neurological conditions, and transplantation. The diagnostics division offers a range of in-vitro tests essential for identifying numerous diseases, including cancer, diabetes, COVID-19, hepatitis, and human papillomavirus (HPV). Beyond tests, it also supplies crucial diagnostic instruments and reagents. Founded in Basel, Switzerland, in 1896, the company maintains its headquarters there.
